A&Z Pharmaceutical Inc. is adding 26,000 square feet of production space to increase the types of generic prescription drugs ...

The most recent analyst rating on (HK:2196) stock is a Buy with a HK$35.30 price target. To see the full list of analyst forecasts on Shanghai Fosun Pharmaceutical (Group) Co stock, see the HK:2196 ...

The UK's drug cost-effectiveness watchdog has recommended Alnylam Pharmaceuticals' heart disease drug, ensuring access for ...

Shares of Ligand PharmaceuticalsLGND are absolutely flying, up more than 92% this year, as investors line up behind the ...

Takeda Pharmaceuticals' drug Adzynma is being investigated by the U.S. Food and Drug Administration due to a death following treatment. The FDA said Friday it has received reports of neutralizing ...

Operated by the federal government, TrumpRx aims to reduce the amount that Americans — including Medicaid patients — pay for ...

Texas Attorney General Ken Paxton has launched a lawsuit against pharmaceutical giants Sanofi and Bristol-Myers Squibb, ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

The U.S. Food and Drug Administration said on Friday it is investigating the death of a child who developed harmful ...

Lilly becomes the first pharmaceutical company to hit that threshold, joining a select club of mostly tech companies.

The settlement resolves a 2023 lawsuit that accused the pharmaceutical companies of manipulating quality control tests of a medication used to treat ADHD.